Interaction of desipramine with steroid hormones on experimental anxiety

Psychoneuroendocrinology

Volumn 25, Issue 2, 2000, Pages 109-120

  Martínez Mota, Lucía ^a,b,c   Estrada Camarena, Erika ^a,b,c   López Rubalcava, Carolina ^a,d   Contreras, Carlos M ^b,c   Fernández Guasti, Alonso ^a,d  

^a Seccion de Terapeutica E   (Mexico)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

^d Instituto Mexicano de P   (Mexico)

Author keywords

Anxiety; Burying behavior; Desipramine; Estradiol; Progesterone

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DESIPRAMINE; ESTRADIOL BENZOATE; PROGESTERONE; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONDITIONING; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; LOCOMOTION; NOCICEPTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0345581401     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(99)00042-6     Document Type: Article

References (43)

1. Bianchi C., David A. Analgesic properties of 4-ethoxycarbonyl-1-(2-hydroxy-3-phenoxypropyl)4-phenylpiperidine (B.D.H.200) and some related compounds. J. Pharm. Pharmacol. 12:1960;449-459.
2. Bitran D., Hilvers R.J., Kellogg C.K. Ovarian endocrine status regulates the anxiolytic potency of diazepam and the efficacy of γ-aminobutyric acid-benzodiazepine receptor-mediated chloride ion transport. Behav. Neurosci. 105:1991;653-662.
3. Bitran D., Purdy R.H., Kellogg C.K. Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABA receptor function. Pharmacol. Biochem. Behav. 45:1993;423-428.
4. A receptors. J. Neuroendocrinol. 7:1995;171-177.
5. Bitran D., Dowd J.A. Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology. 125:1996;573-583.
6. Bodnoff S.R., Suranyi-Cadotte B., Aitken D.H., Quirion R., Meaney M.J. The effect of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology. 95:1988;298-302.
7. Bodnoff S.R., Suranyi-Cadotte B., Quirion R., Meaney M.J. A comparison of the effects of diazepam versus several typical and atypical antidepressant drugs in an animal model of anxiety. Psychopharmacology. 97:1989;277-279.
8. Caba M., González-Mariscal G., Beyer C. Perispinal progestins enhance the antinociceptive effects of muscimol in the rat. Pharmacol. Biochem. Behav. 47:1994;177-182.
9. Dawson-Basoa M.E., Gintzler A.R. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms. Pain. 64:1996;608-615.
10. De Wit H., Rukstalis M. Acute effects of triazolam in women: relationship with progesterone, estradiol and allopregnanolone. Psychopharmacology. 130:1997;69-78.
11. Endicott J., Halbreich U. Clinical significance of premenstrual dysphoric changes. J. Clin. Psychiatry. 49:1988;486-489.
12. Fernández-Guasti A., Picazo O. The actions of diazepam and serotonergic anxiolytics vary according to the gender and the estrous cycle phase. Pharmacol. Biochem. Behav. 37:1990;77-81.
13. Fernández-Guasti A., Picazo O. Changes in burying behavior during the estrous cycle: effects of estrogen and progesterone. Psychoneuroendocrinology. 17:1992;681-689.
14. Fernández-Guasti A., Contreras C.M., Martínez-Mota L., Estrada-Camarena E., López-Rubalcava C. Chronic treatment with desipramine induces an estrous cycle dependent anxiolytic action in the burying behavior but not in the plus maze. Pharmacol. Biochem. Behav. 63:1999;13-20.
15. Fernández-Teruel A., Escorihuela R.M., Boix F., Longoni B., Corda M.G., Tobeña A. Imipramine and desipramine decrease the GABA-stimulated chloride uptake, and antiGABAergic agents enhance their action in the forced swimming test in rats. Neuropsychobiology. 23:1990;147-152.
16. Freeman M.E. The ovarian cycle of the rat. Knobil E., Neill J.D. The Physiology of Reproduction. 2:1988;1893-1928 Raven Press, New York.
17. Green A.F., Young P.A. A comparison of heat and pressure analgesiometric methods in rats. Br. J. Pharmacol. 6:1951;572-585.
18. Halbreich U., Endicott J., Goldstein S., Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr. Scand. 74:1986;576-586.
19. Hersh E.V., Kaplan P. Antinociceptive action of tricyclic antidepressants drugs in the rat. Anesth. Prog. 37:1990;186-189.
20. Kunihara M., Ohyama M., Nakano M. Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective kappa-opioid receptor agonist. Eur. J. Pharmacol. 214:1992;111-118.
21. Laino C.H., Cordoba N.E., Orsingher O.A. Perinatally protein-deprived rats and reactivity to anxiolytic drugs in the plus-maze test: an animal model for screening antipanic agents? Pharmacol. Biochem. Behav. 46:1993;89-94.
22. Lakoski J.M. Cellular electrophysiological approaches to the central regulation of female reproductive aging. Lakoski J.M., Perez-Polo J.L., Rassin D.K. Neurology and Neurobiology, Neural Control of Reproductive Function. 50:1989;209-220 Liss, New York.
23. A compounds. Dev. Psychobiol. 29:1996;157-169.
24. Lund A., Mjellem-Holy N., Hole K. Desipramine, administered chronically influences 5-hydroxytryptamine 1A-receptors as measured by behavioral tests and receptor binding in rats. Neuropharmacology. 31:1992;25-32.
25. Lydiard R.B., Morton W.A., Emmanuel N.P., Zealberg J.J., Laraia M.T., Stuart G.W., O'Neil P.M., Ballenger J.C. Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacol. Bull. 29:1995;183-188.
26. Majewska M.D., Harrison W.L., Schwartz R.A., Barker M., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
27. A receptor: mechanism of action and physiological significance. Prog. Neurobiol. 38:1992;379-395.
28. McDougle C.J., Goodman W.K., Price L.H. The pharmacotherapy of obsessive-compulsive disorder. Pharmaco-phsychiatry. 26(Suppl 1):1993;24-29.
29. Molewijk H.E., Hartog K., van der Poel A.M., Moss J., Olivier B. Reduction of guinea pig pups isolation calls by anxiolytic and antidepressant drugs. Psychopharmacology. 128:1996;31-38.
30. Nutt D.J., Glue P. Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Bowman W.C. Psychopharmacology of Anxiolytics and Antidepressants. 1991;1-15 Pergamon, Glasgow.
31. A receptor mRNA expression in the limbic system of female rats. Mol. Brain Res. 55:1998;169-172.
32. Pearlstein T.B. Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am. J. Obstet. Gynecol. 173:1995;646-653.
33. Pérez J., Zucchi Y., Maggi A. Estrogen modulation of the γ-amino butyric acid receptor complex in the central nervous system of the rat. J. Pharmacol. Exp. Ther. 244:1987;1005-1010.
34. Peroutka S.J., Snyder S.H. Long-term antidepressant treatment lowering spiperidol labeled serotonin receptor binding. Science. 210:1980;88.
35. Pertovaara A., Mecke E., Carlson S. Attempted reversal of cocaine-induced antinociceptive effect with naloxone, and opioid antagonist. Eur. J. Pharmacol. 192:1991;349-353.
36. Petty F., Sherman A.D. GABAergic modulation of learned helplessness. Pharmacol. Biochem. Behav. 15:1981;567-570.
37. Rodríguez-Sierra J.F., Howard J.L., Pollard G.T., Hendricks S.E. Effect of ovarian hormones on conflict behavior. Psychoneuroendocrinology. 9:1984;293-300.
38. A agonist, 8-OH-DPAT. Pharmacol. Biochem. Behav. 43:1992;953-956.
39. Schreiber R., De Vry J. 5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanism of action? Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 17:1993;87-104.
40. A receptors coupled to 35S-t-butyl-bicyclophosphorothionate binding sites in rat brain. Brain Res. 441:1988;15-22.
41. Stahl S.M. Basic pharmacology of antidepressants, Part 22: estrogen as an adjunct to antidepressant treatment. J. Clin. Psychiatry. 59(Suppl 4):1998;15-25.
42. Suranyi-Cadotte B.E., Bodnoff S.R., Welner S.A. Antidepressant-anxiolytic interactions: involvement of the benzodiazepine-GABA and serotonin systems. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 14:1990;633-654.
43. Treit D. Animal models for the study of anti-anxiety agents: a review. Neurosci. Biobehav. Rev. 9:1985;203-222.